Cargando…

Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge

BACKGROUND: To elucidate the clinical and ancillary features of genetic prion diseases (gPrDs) presenting with frontotemporal dementia (FTD) to aid early identification. METHODS: Global data of gPrDs presenting with FTD caused by prion protein gene mutations were collected from literature review and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhongyun, Chu, Min, Liu, Li, Zhang, Jing, Kong, Yu, Xie, Kexin, Cui, Yue, Ye, Hong, Li, Junjie, Wang, Lin, Wu, Liyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245249/
https://www.ncbi.nlm.nih.gov/pubmed/35768878
http://dx.doi.org/10.1186/s13195-022-01033-4
_version_ 1784738706077253632
author Chen, Zhongyun
Chu, Min
Liu, Li
Zhang, Jing
Kong, Yu
Xie, Kexin
Cui, Yue
Ye, Hong
Li, Junjie
Wang, Lin
Wu, Liyong
author_facet Chen, Zhongyun
Chu, Min
Liu, Li
Zhang, Jing
Kong, Yu
Xie, Kexin
Cui, Yue
Ye, Hong
Li, Junjie
Wang, Lin
Wu, Liyong
author_sort Chen, Zhongyun
collection PubMed
description BACKGROUND: To elucidate the clinical and ancillary features of genetic prion diseases (gPrDs) presenting with frontotemporal dementia (FTD) to aid early identification. METHODS: Global data of gPrDs presenting with FTD caused by prion protein gene mutations were collected from literature review and our records. Fifty-one cases of typical FTD and 136 cases of prion diseases admitted to our institution were included as controls. Clinical and ancillary data of the different groups were compared. RESULTS: Forty-nine cases of gPrDs presenting with FTD were identified. Compared to FTD or prion diseases, gPrDs presenting with FTD were characterized by earlier onset age (median 45 vs. 61/60 years, P < 0.001, P < 0.001) and higher incidence of positive family history (81.6% vs. 27.5/13.2%, P < 0.001, P < 0.001). Furthermore, GPrDs presenting with FTD exhibited shorter duration (median 5 vs. 8 years) and a higher rate of parkinsonism (63.7% vs. 9.8%, P < 0.001), pyramidal signs (39.1% vs. 7.8%, P = 0.001), mutism (35.9% vs. 0%, P < 0.001), seizures (25.8% vs. 0%, P < 0.001), myoclonus (22.5% vs. 0%, P < 0.001), and hyperintensity on MRI (25.0% vs. 0, P < 0.001) compared to FTD. Compared to prion diseases, gPrDs presenting with FTD had a longer duration of symptoms (median 5 vs. 1.1 years, P < 0.001), higher rates of frontotemporal atrophy (89.7% vs. 3.3%, P < 0.001), lower rates of periodic short-wave complexes on EEG (0% vs. 30.3%, P = 0.001), and hyperintensity on MRI (25.0% vs. 83.0%, P < 0.001). The frequency of codon 129 Val allele in gPrDs presenting with FTD was significantly higher than that reported in the literature for gPrDs in the Caucasian and East Asian populations (33.3% vs. 19.2%/8.0%, P = 0.005, P < 0.001). CONCLUSIONS: GPrDs presenting with FTD are characterized by early-onset, high incidence of positive family history, high frequency of the Val allele at codon 129, overlapping symptoms with prion disease and FTD, and ancillary features closer to FTD. PRNP mutations may be a rare cause in the FTD spectrum, and PRNP genotyping should be considered in patients with these features. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01033-4.
format Online
Article
Text
id pubmed-9245249
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92452492022-07-01 Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge Chen, Zhongyun Chu, Min Liu, Li Zhang, Jing Kong, Yu Xie, Kexin Cui, Yue Ye, Hong Li, Junjie Wang, Lin Wu, Liyong Alzheimers Res Ther Research BACKGROUND: To elucidate the clinical and ancillary features of genetic prion diseases (gPrDs) presenting with frontotemporal dementia (FTD) to aid early identification. METHODS: Global data of gPrDs presenting with FTD caused by prion protein gene mutations were collected from literature review and our records. Fifty-one cases of typical FTD and 136 cases of prion diseases admitted to our institution were included as controls. Clinical and ancillary data of the different groups were compared. RESULTS: Forty-nine cases of gPrDs presenting with FTD were identified. Compared to FTD or prion diseases, gPrDs presenting with FTD were characterized by earlier onset age (median 45 vs. 61/60 years, P < 0.001, P < 0.001) and higher incidence of positive family history (81.6% vs. 27.5/13.2%, P < 0.001, P < 0.001). Furthermore, GPrDs presenting with FTD exhibited shorter duration (median 5 vs. 8 years) and a higher rate of parkinsonism (63.7% vs. 9.8%, P < 0.001), pyramidal signs (39.1% vs. 7.8%, P = 0.001), mutism (35.9% vs. 0%, P < 0.001), seizures (25.8% vs. 0%, P < 0.001), myoclonus (22.5% vs. 0%, P < 0.001), and hyperintensity on MRI (25.0% vs. 0, P < 0.001) compared to FTD. Compared to prion diseases, gPrDs presenting with FTD had a longer duration of symptoms (median 5 vs. 1.1 years, P < 0.001), higher rates of frontotemporal atrophy (89.7% vs. 3.3%, P < 0.001), lower rates of periodic short-wave complexes on EEG (0% vs. 30.3%, P = 0.001), and hyperintensity on MRI (25.0% vs. 83.0%, P < 0.001). The frequency of codon 129 Val allele in gPrDs presenting with FTD was significantly higher than that reported in the literature for gPrDs in the Caucasian and East Asian populations (33.3% vs. 19.2%/8.0%, P = 0.005, P < 0.001). CONCLUSIONS: GPrDs presenting with FTD are characterized by early-onset, high incidence of positive family history, high frequency of the Val allele at codon 129, overlapping symptoms with prion disease and FTD, and ancillary features closer to FTD. PRNP mutations may be a rare cause in the FTD spectrum, and PRNP genotyping should be considered in patients with these features. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01033-4. BioMed Central 2022-06-29 /pmc/articles/PMC9245249/ /pubmed/35768878 http://dx.doi.org/10.1186/s13195-022-01033-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Zhongyun
Chu, Min
Liu, Li
Zhang, Jing
Kong, Yu
Xie, Kexin
Cui, Yue
Ye, Hong
Li, Junjie
Wang, Lin
Wu, Liyong
Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge
title Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge
title_full Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge
title_fullStr Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge
title_full_unstemmed Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge
title_short Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge
title_sort genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245249/
https://www.ncbi.nlm.nih.gov/pubmed/35768878
http://dx.doi.org/10.1186/s13195-022-01033-4
work_keys_str_mv AT chenzhongyun geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge
AT chumin geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge
AT liuli geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge
AT zhangjing geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge
AT kongyu geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge
AT xiekexin geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge
AT cuiyue geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge
AT yehong geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge
AT lijunjie geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge
AT wanglin geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge
AT wuliyong geneticpriondiseasespresentingasfrontotemporaldementiaclinicalfeaturesanddiagnosticchallenge